Display options
Cite
Schecker M, Pirnay-Dummer P, Schmidtke K, et al. Cognitive interventions in mild Alzheimer's disease: a therapy-evaluation study on the interaction of medication and cognitive treatment. Dement Geriatr Cogn Dis Extra. 2013;3(1):301-11doi: 10.1159/000354190.
Schecker, M., Pirnay-Dummer, P., Schmidtke, K., Hentrich-Hesse, T., & Borchardt, D. (2013). Cognitive interventions in mild Alzheimer's disease: a therapy-evaluation study on the interaction of medication and cognitive treatment. Dementia and geriatric cognitive disorders extra, 3(1), 301-11. https://doi.org/10.1159/000354190
Schecker, M, et al. "Cognitive interventions in mild Alzheimer's disease: a therapy-evaluation study on the interaction of medication and cognitive treatment." Dementia and geriatric cognitive disorders extra vol. 3,1 (2013): 301-11. doi: https://doi.org/10.1159/000354190
Schecker M, Pirnay-Dummer P, Schmidtke K, Hentrich-Hesse T, Borchardt D. Cognitive interventions in mild Alzheimer's disease: a therapy-evaluation study on the interaction of medication and cognitive treatment. Dement Geriatr Cogn Dis Extra. 2013 Sep 24;3(1):301-11. doi: 10.1159/000354190. eCollection 2013. PMID: 24174925; PMCID: PMC3808226.
Copy Download .nbib Format: NLM
Share it on

Dement Geriatr Cogn Dis Extra. 2013 Sep 24;3(1):301-11. doi: 10.1159/000354190. eCollection 2013.

Cognitive interventions in mild Alzheimer's disease: a therapy-evaluation study on the interaction of medication and cognitive treatment.

Dementia and geriatric cognitive disorders extra

M Schecker, P Pirnay-Dummer, K Schmidtke, T Hentrich-Hesse, D Borchardt

Affiliations

  1. Neurolinguistisches Labor NLL, Forschungsbereich 'Kognitive und Klinische Neurowissenschaften', Kinder- und Jugendpsychiatrie, Germany.

PMID: 24174925 PMCID: PMC3808226 DOI: 10.1159/000354190

Abstract

BACKGROUND/AIMS: Many studies have shown that not only pharmacological treatment but also cognitive stimulation in the early stages of Alzheimer's disease (AD) improves language processing and (other) cognitive functions, stabilizes Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) functions and increases the subjective quality of life (wherein a combination of pharmacological intervention and cognitive stimulation could provide greater relief of clinical symptoms than either intervention given alone). Today, it is no longer the question of whether cognitive stimulation helps but rather what kind of stimulation helps more than others.

METHODS: A sample of 42 subjects with mild AD (all medicated with an acetylcholinesterase inhibitor and well adjusted) underwent clinical and cognitive evaluation and participated in a 6-month study with 2 experimental groups (i.e. 'client-centered' global stimulation vs. cognitive training) and a control group. Since the test performance also depends on the individual test, we used a wide variety of tests; we z-transformed the results and then calculated the mean value for the global cognitive status (using the Mini-Mental State Examination) as well as for the single functional areas.

RESULTS: Between-group differences were found, they were overall in favor of the experimental groups. Different functional areas led to different treatment and test patterns. Client-centered, global, cognitive therapy stimulated many cognitive functions and thus led to a better performance in language processing and ADL/IADL. The subjective quality of life increased as well. The cognitive training (of working memory) improved only the ADL/IADL performance (more, however, than client-centered, global, cognitive stimulation) and stabilized the level of performance in the other three functional areas. © 2013 S. Karger AG, Basel.

Keywords: Alzheimer's disease; Cognitive stimulation therapy; Functional areas

References

  1. J Psychiatr Res. 1975 Nov;12(3):189-98 - PubMed
  2. Md State Med J. 1965 Feb;14:61-5 - PubMed
  3. J Am Geriatr Soc. 1991 Apr;39(4):339-47 - PubMed
  4. Health Technol Assess. 2005 Mar;9(10):1-93, iii-iv - PubMed
  5. Expert Rev Neurother. 2008 May;8(5):751-7 - PubMed
  6. Am J Psychiatry. 1984 Nov;141(11):1356-64 - PubMed
  7. Philos Trans R Soc Lond B Biol Sci. 2007 May 29;362(1481):901-15 - PubMed
  8. J Psychiatr Res. 1982-1983;17(1):37-49 - PubMed
  9. Dement Geriatr Cogn Disord. 2001 Sep-Oct;12(5):348-58 - PubMed
  10. Neurology. 1994 Apr;44(4):609-14 - PubMed
  11. Dement Geriatr Cogn Disord. 2006;22(4):339-45 - PubMed
  12. J Speech Lang Hear Res. 2004 Oct;47(5):1149-63 - PubMed
  13. Gerontologist. 1969 Autumn;9(3):179-86 - PubMed
  14. Clin Rehabil. 2005 Dec;19(8):861-9 - PubMed
  15. Psychopharmacol Bull. 1988;24(4):641-52 - PubMed
  16. J Gerontol Nurs. 2009 Mar;35(3):23-9 - PubMed
  17. Dement Geriatr Cogn Disord. 1998;9 Suppl 2:20-6 - PubMed
  18. Stud Health Technol Inform. 2000;77:195-9 - PubMed
  19. Brain Lang. 1999 May;67(3):202-27 - PubMed
  20. Cochrane Database Syst Rev. 2003;(4):CD003260 - PubMed
  21. Neurology. 1984 Jul;34(7):939-44 - PubMed
  22. J Int Neuropsychol Soc. 2010 Sep;16(5):910-20 - PubMed
  23. J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):146-8 - PubMed

Publication Types